Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alkermes Plc (ALKS)  
$24.49 0.22 (0.89%) as of 4:30 Tue 5/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 183,678,000
Market Cap: 4.50(B)
Last Volume: 775,760 Avg Vol: 773,615
52 Week Range: $23.37 - $33.63
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Delivery

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  581
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alkermes is a biopharmaceutical company. Co. has a portfolio of marketed products focused on central nervous system disorders such as addiction and schizophrenia and a pipeline of product candidates in the fields of neuroscience and oncology. Co.'s proprietary products include: ARISTADA, which is an extended-release intramuscular injectable suspension approved in the U.S. for the treatment of schizophrenia; ARISTADA INITIO, which is indicated for the initiation of ARISTADA when used for the treatment of schizophrenia in adults; and VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence, following opioid detoxification.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 35,000
Total Buy Value $0 $0 $0 $815,735
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 15,666 15,666 48,238 146,962
Total Sell Value $454,291 $454,291 $1,411,373 $4,368,837
Total People Sold 3 3 3 5
Total Sell Transactions 3 3 6 9
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 1496
  Page 15 of 60  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-05-11 4 OE $18.11 $2,715,750 D/D 150,000 942,040     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-05-07 4 AS $22.10 $430,522 D/D (19,477) 216,781 35%     
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-05-07 4 OE $18.11 $352,631 D/D 19,477 236,258     -
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-05-06 4 AS $21.79 $2,179,410 D/D (100,000) 792,040 39%     
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-05-06 4 OE $18.11 $1,810,500 D/D 100,000 892,040     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-05-03 4 AS $22.18 $765,156 D/D (34,503) 68,154 38%     
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-05-03 4 OE $18.11 $624,677 D/D 34,503 102,657     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-04-19 4 AS $20.00 $695,760 D/D (34,792) 48,362 52%     
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-04-19 4 OE $18.11 $629,909 D/D 34,792 83,154     -
   Dixon Wendy L Director   •       •      –    2021-04-19 4 AS $20.00 $500,120 D/D (25,000) 36,600 52%     
   Dixon Wendy L Director   •       •      –    2021-04-19 4 OE $14.60 $365,000 D/D 25,000 61,600     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-04-16 4 AS $19.99 $4,158 D/D (208) 48,362 54%     
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-04-16 4 OE $18.11 $3,766 D/D 208 48,570     -
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2021-04-15 4 AS $19.72 $570,288 D/D (28,920) 0 54%     
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2021-02-21 4 D $19.58 $39,591 D/D (2,022) 28,920     -
   Hopkinson Craig C. EVP R&D, Chief Medical Officer   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 6,875 30,942     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-21 4 D $19.58 $27,647 D/D (1,412) 68,154     -
   Jackson Blair Curtis EVP, Chief Operating Officer   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 4,800 69,566     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-21 4 D $19.58 $39,591 D/D (2,022) 74,597     -
   Gaffin David Joseph SVP, CLO, Alkermes, Inc.   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 6,875 76,619     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-21 4 D $19.58 $27,647 D/D (1,412) 48,362     -
   Brown Iain Michael SVP, Chief Financial Officer   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 4,800 49,774     -
   Landine Michael J SVP, Corp Dev., Alkermes, Inc.   •       •      –    2021-02-21 4 D $19.58 $50,653 D/D (2,587) 216,781     -
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-02-21 4 D $19.58 $281,678 D/D (14,386) 792,040     -
   Pops Richard F Director and CEO, Alkermes plc   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 32,400 806,426     -
  1496 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 15 of 60
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us